{"DataElement":{"publicId":"3534839","version":"1","preferredName":"Preventive Intervention Pharmacotherapy Name Preventive Intervention Agent Name","preferredDefinition":"Name of a prophylactic analgesic agent","longName":"3534838v1.0:2588582v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3534838","version":"1","preferredName":"Preventive Intervention Pharmacotherapy Name","preferredDefinition":"An attempt to prevent disease._Treatment of disease through the use of drugs._The words or language units by which a thing is known.","longName":"3235614v1.0:2222841v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3235614","version":"1","preferredName":"Preventive Intervention Pharmacotherapy","preferredDefinition":"An attempt to prevent disease.:Treatment of disease through the use of drugs.","longName":"C15843:C15986","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pharmacotherapy","conceptCode":"C15986","definition":"Treatment of disease through the use of drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A36879F5-FCCE-D459-E040-BB89AD4362C2","latestVersionIndicator":"Yes","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"ONEDATA","dateModified":"2011-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222841","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6211245-8062-4DD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5A1634D-C56F-CDBE-E040-BB89AD4318FF","latestVersionIndicator":"Yes","beginDate":"2012-07-25","endDate":null,"createdBy":"RODGERSC","dateCreated":"2012-07-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"created for UAMS 7/24/12 cmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2588582","version":"1","preferredName":"Preventive Intervention Agent Name","preferredDefinition":"the name of a prophylactic agent.","longName":"PREV_AGT_NM","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Aspirin 325mg","valueDescription":"Aspirin 325mg","ValueMeaning":{"publicId":"2588583","version":"1","preferredName":"Aspirin 325mg","longName":"2588583","preferredDefinition":"Aspirin 325mg","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2754903E-832C-3705-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2754903E-8346-3705-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-18","modifiedBy":"CAMPBELB","dateModified":"2007-01-18","deletedIndicator":"No"},{"value":"Coumadin","valueDescription":"Coumadin (prophylactic dose)","ValueMeaning":{"publicId":"2580721","version":"1","preferredName":"Coumadin (prophylactic dose)","longName":"2580721","preferredDefinition":"a prophylactic dose of the anticoagulant Coumadin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-085E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"CAMPBELB","dateModified":"2006-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2754903E-835B-3705-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-18","modifiedBy":"CAMPBELB","dateModified":"2007-01-18","deletedIndicator":"No"},{"value":"Low Molecular Weight Heparin","valueDescription":"Low Molecular Weight Heparin (prophylactic dose)","ValueMeaning":{"publicId":"2580726","version":"1","preferredName":"Low Molecular Weight Heparin (prophylactic dose)","longName":"2580726","preferredDefinition":"a prophylactic dose of the anticoagulant Low Molecular Weight Heparin.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0863-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"CAMPBELB","dateModified":"2006-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2754903E-8370-3705-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-18","modifiedBy":"CAMPBELB","dateModified":"2007-01-18","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2754AC96-6EF6-3626-E044-0003BA3F9857","beginDate":"2007-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-18","modifiedBy":"ONEDATA","dateModified":"2007-01-18","deletedIndicator":"No"},{"value":"Aspirin, other","valueDescription":"Aspirin, other","ValueMeaning":{"publicId":"2588585","version":"1","preferredName":"Aspirin, other","longName":"2588585","preferredDefinition":"Another dosage amount of acetylsalicylic acid.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2754A2CD-76C2-39D3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2754853E-E7E4-340B-E044-0003BA3F9857","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-18","modifiedBy":"CAMPBELB","dateModified":"2007-01-18","deletedIndicator":"No"},{"value":"Aspirin 81 mg","valueDescription":"Aspirin 81mg","ValueMeaning":{"publicId":"2580724","version":"1","preferredName":"Aspirin 81mg","longName":"2580724","preferredDefinition":"Aspirin 81mg","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0861-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-08-31","modifiedBy":"CAMPBELB","dateModified":"2006-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"406501AA-E73E-544A-E044-0003BA3F9857","beginDate":"2007-12-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-12-03","modifiedBy":"ONEDATA","dateModified":"2007-12-03","deletedIndicator":"No"},{"value":"Topical Oral Analgesic","valueDescription":"Topical Oral Analgesics","ValueMeaning":{"publicId":"3534411","version":"1","preferredName":"Topical Oral Analgesics","longName":"3534411","preferredDefinition":"On the surface of the body.: Oral; of, or relating to, or affecting, or for use in the mouth.: Drugs that reduce pain. These drugs include aspirin, acetaminophen, and ibuprofen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Topical","conceptCode":"C13344","definition":"On the surface of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Oral","conceptCode":"C25311","definition":"Of, or relating to, or affecting, or for use in the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Analgesic Agent","conceptCode":"C241","definition":"Compounds that alleviate pain without loss of consciousness.  Analgesics act by various mechanisms including binding with opioid receptors and decreasing inflammation.  Choice of analgesic may be determined by the type of pain.  These compounds include opioid, non-opioid and adjuvant analgesic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5836E1A-D917-6E19-E040-BB89AD434FC8","latestVersionIndicator":"Yes","beginDate":"2012-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C5836E1A-D930-6E19-E040-BB89AD434FC8","beginDate":"2012-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-23","modifiedBy":"ONEDATA","dateModified":"2012-07-23","deletedIndicator":"No"},{"value":"Opiate substitute","valueDescription":"Substitution Opiate","ValueMeaning":{"publicId":"3534412","version":"1","preferredName":"Substitution Opiate","longName":"3534412","preferredDefinition":"The act of putting one thing or person in the place of another.: Functionally related to the poppy (Papaver somniferum) alkaloid morphine, natural or synthetic Opiates have widespread effects in the central nervous system, and on smooth muscle, due to activation of specific delta, mu, and kappa opiate receptors (each controlling different brain functions). Opiates include natural ingredients of the poppy and their derivatives - opium, morphine, codeine, and heroin. Morphine preparations are used as analgesic, sedative, or anxiolytic agent, but are also abused as street drugs. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Substitution","conceptCode":"C54071","definition":"The act of putting one thing or person in the place of another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Opiate","conceptCode":"C1657","definition":"Functionally related to the poppy (Papaver somniferum) alkaloid morphine, natural or synthetic Opiates have widespread effects in the central nervous system, and on smooth muscle, due to activation of specific delta, mu, and kappa opiate receptors (each controlling different brain functions). Opiates include natural ingredients of the poppy and their derivatives - opium, morphine, codeine, and heroin. Morphine preparations are used as analgesic, sedative, or anxiolytic agent, but are also abused as street drugs. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5836E1A-D93D-6E19-E040-BB89AD434FC8","latestVersionIndicator":"Yes","beginDate":"2012-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C5836E1A-D956-6E19-E040-BB89AD434FC8","beginDate":"2012-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-23","modifiedBy":"ONEDATA","dateModified":"2012-07-23","deletedIndicator":"No"},{"value":"Dexamethasone","valueDescription":"Dexamethasone","ValueMeaning":{"publicId":"3028376","version":"1","preferredName":"Dexamethasone","longName":"3028376","preferredDefinition":"A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04) [Source: NCI]","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dexamethasone","conceptCode":"C422","definition":"A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8223B6A1-980B-C0E8-E040-BB89AD43538F","latestVersionIndicator":"Yes","beginDate":"2010-03-19","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-03-19","modifiedBy":"KUMMEROA","dateModified":"2022-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C5836E1A-D960-6E19-E040-BB89AD434FC8","beginDate":"2012-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-23","modifiedBy":"ONEDATA","dateModified":"2012-07-23","deletedIndicator":"No"},{"value":"Opiate","valueDescription":"Opiate","ValueMeaning":{"publicId":"3534413","version":"1","preferredName":"Opiate","longName":"3534413","preferredDefinition":"Functionally related to the poppy (Papaver somniferum) alkaloid morphine, natural or synthetic Opiates have widespread effects in the central nervous system, and on smooth muscle, due to activation of specific delta, mu, and kappa opiate receptors (each controlling different brain functions). Opiates include natural ingredients of the poppy and their derivatives - opium, morphine, codeine, and heroin. Morphine preparations are used as analgesic, sedative, or anxiolytic agent, but are also abused as street drugs. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Opiate","conceptCode":"C1657","definition":"Functionally related to the poppy (Papaver somniferum) alkaloid morphine, natural or synthetic Opiates have widespread effects in the central nervous system, and on smooth muscle, due to activation of specific delta, mu, and kappa opiate receptors (each controlling different brain functions). Opiates include natural ingredients of the poppy and their derivatives - opium, morphine, codeine, and heroin. Morphine preparations are used as analgesic, sedative, or anxiolytic agent, but are also abused as street drugs. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5836E1A-D96C-6E19-E040-BB89AD434FC8","latestVersionIndicator":"Yes","beginDate":"2012-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C5836E1A-D985-6E19-E040-BB89AD434FC8","beginDate":"2012-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-23","modifiedBy":"ONEDATA","dateModified":"2012-07-23","deletedIndicator":"No"},{"value":"Fentanyl patch","valueDescription":"Fentanyl Matrix Transdermal Patch","ValueMeaning":{"publicId":"3534415","version":"1","preferredName":"Fentanyl Matrix Transdermal Patch","longName":"3534415","preferredDefinition":"A transdermal formulation containing the synthetic phenylpiperidine opioid agonist fentanyl, with analgesic activity. Upon topical administration, fentanyl diffuses from the transdermal patch through the skin, is transported via the systemic circulation, and selectively binds to the mu-receptor in the central nervous system (CNS), mimicking the effects of endogenous opiates. Stimulation of the mu-receptor inhibits adenyl cyclase activity, induces opening of G-protein-coupled inwardly rectifying potassium (GIRK) channels, and blocks the opening of N-type voltage-gated calcium channels, resulting in hyperpolarization and reduced neuronal excitability; in addition, neuronal release of neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline may decrease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fentanyl Matrix Transdermal Patch","conceptCode":"C80067","definition":"A transdermal formulation containing the synthetic phenylpiperidine opioid agonist fentanyl, with analgesic activity. Upon topical administration, fentanyl diffuses from the transdermal patch through the skin, is transported via the systemic circulation, and selectively binds to the mu-receptor in the central nervous system (CNS), mimicking the effects of endogenous opiates. Stimulation of the mu-receptor inhibits adenyl cyclase activity, induces opening of G-protein-coupled inwardly rectifying potassium (GIRK) channels, and blocks the opening of N-type voltage-gated calcium channels, resulting in hyperpolarization and reduced neuronal excitability; in addition, neuronal release of neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline may decrease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5836E1A-D992-6E19-E040-BB89AD434FC8","latestVersionIndicator":"Yes","beginDate":"2012-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C5836E1A-D9AB-6E19-E040-BB89AD434FC8","beginDate":"2012-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-23","modifiedBy":"ONEDATA","dateModified":"2012-07-23","deletedIndicator":"No"},{"value":"Nonsteroidal Antiinflammatory Drug","valueDescription":"Nonsteroidal Antiinflammatory Drug","ValueMeaning":{"publicId":"2578060","version":"1","preferredName":"Nonsteroidal Antiinflammatory Drug","longName":"2578060","preferredDefinition":"Anti-inflammatory agents that are not steroids. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Certain NSAIDs also may inhibit lipoxygenase enzymes or phospholipase C or may modulate T-cell function. (AMA Drug Evaluations Annual, 1994, p 1814-5)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nonsteroidal Antiinflammatory Drug","conceptCode":"C257","definition":"A pharmacological agent that is not a steroid and has potential anti-inflammatory, analgesic, antipyretic and anti-platelet activities. Most nonsteroidal anti-inflammatory drugs (NSAIDs) act by inhibiting the conversion of arachidonic acid to the precursors of prostaglandin and thromboxane by cyclooxygenase enzymes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDF9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"ONEDATA","dateModified":"2006-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C5836E1A-D9BF-6E19-E040-BB89AD434FC8","beginDate":"2012-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-23","modifiedBy":"ONEDATA","dateModified":"2012-07-23","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2839905","version":"1","preferredName":"Other","longName":"2839905","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"635B8107-2331-1337-E040-BB89AD432C60","latestVersionIndicator":"Yes","beginDate":"2009-02-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C5836E1A-D9CA-6E19-E040-BB89AD434FC8","beginDate":"2012-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-23","modifiedBy":"ONEDATA","dateModified":"2012-07-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2754851C-5B61-32BF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-18","modifiedBy":"CAMPBELB","dateModified":"2015-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3029677","version":"1","longName":"UAMS Clinical Research","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812848","version":"1","longName":"UAMS New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Analgesia sources:","type":"Preferred Question Text","description":"Analgesia sources:","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5A1634D-C587-CDBE-E040-BB89AD4318FF","latestVersionIndicator":"Yes","beginDate":"2012-07-25","endDate":null,"createdBy":"RODGERSC","dateCreated":"2012-07-25","modifiedBy":"RODGERSC","dateModified":"2015-02-25","changeDescription":"created for UAMS 7/24/12 cmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}